Helix Acquisition Corp
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch HLXB and buy or sell other stocks, ETFs, and their options commission-free!About HLXB
Bridgebio Oncology Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It focuses on advancing a next-generation pipeline of novel small molecule therapeutics targeting RAS and PI3Ka malignancies.
CEOEli M. Wallace, PhD
CEOEli M. Wallace, PhD
Employees—
Employees—
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded
Founded
Employees—
Employees—
HLXB Key Statistics
Market cap784.05M
Market cap784.05M
Price-Earnings ratio-13.57
Price-Earnings ratio-13.57
Dividend yield—
Dividend yield—
Average volume222.26K
Average volume222.26K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$14.87
52 Week high$14.87
52 Week low$8.70
52 Week low$8.70
Stock Snapshot
As of today, Helix Acquisition Corp(HLXB) shares are valued at $9.90. The company's market cap stands at 784.05M, with a P/E ratio of -13.57.
Helix Acquisition Corp(HLXB) stock opened on 2025-12-13 at —. The price climbed to — and dipped to —.
Helix Acquisition Corp(HLXB) shares are trading with a volume of 0, against a daily average of 222.26K.
In the last year, Helix Acquisition Corp(HLXB) shares hit a 52-week high of $14.87 and a 52-week low of $8.70.
In the last year, Helix Acquisition Corp(HLXB) shares hit a 52-week high of $14.87 and a 52-week low of $8.70.
People also own
Based on the portfolios of people who own HLXB. This list is generated using Robinhood data, and it’s not a recommendation.